Hedvig Hricak

Hedvig Hricak is a board-certified radiologist focused on molecular imaging, primarily of prostate and gynecologic tumors, providing research toward the establishment of phenotypic signatures of cancer. Dr. Hricak’s lab is working to create tumor biomarkers for use in treatment selection and assessment in the case of early-detected treatment resistance, ultimately resulting in a deeper understanding of in-vivo tumor biology and special and temporal tumor heterogeneity.

Dr. Hricak is the Chair of the Department of Radiology at Memorial Sloan Kettering Cancer Center (MSKCC) since 1999, and serves as a Member of the Institute of Medicine and a Professor at the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences. Previously, she served as a member of the Scientific Advisory Board of the NCI and NIBB; Chairwoman of the NAS Committee on the State of the Science of Nuclear Medicine; President of the Radiological Society of North America and President of the California Academy of Medicine.

Dr. Hedvig Hricak has been spearheading the use of MRI and CT for gynecologic cancers, and promotes international collaboration in all areas of medicine due to her belief that “medicine has no borders”. She has contributed to several breast cancer screening programs, breast imaging training programs and ultrasound training programs in developing countries.

Dr. Hricak’s work has earned an honorary doctorate in medicine from the Ludwig Maximilian University of Munich, Germany and inclusion in twelve radiological societies around the world. She has also been honored with the Marie Curie Award from the Society of Women in Radiology, the Schinz Medal of the Swiss Society of Radiology, the Jean A Vezina French Canadian Award of Innovation and the Order of the Croatian Morning Star of Katarina Zrinska Presidential Award of Croatia.